Xu Dong Zhang

Immunology · 2016–2021

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Xu Dong Zhang trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll (in Immunology)

Papers from Xu Dong Zhang's perspective

Ordered by how strongly the researchers Xu Dong Zhang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
  2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)
  4. Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (Science Translational Medicine)
  5. PD-L2 is a second ligand for PD-1 and inhibits T cell activation (Nature Immunology)
  6. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection (Nature Immunology)
  7. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells (Journal of Experimental Medicine)
  8. Programmed death ligand-1 expression in non-small cell lung cancer (Laboratory Investigation)
  9. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. (New England Journal of Medicine)
  10. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. (Blood)

Their papers